agilon health CFO receives substantial equity awards and enhanced severance

summarizeSummary

agilon health, inc. has amended its employment agreement with CFO Jeffrey Schwaneke, granting him significant equity awards totaling over $4.2 million for fiscal year 2026 and enhanced severance provisions.

check_boxKey Events

• CFO Employment Agreement Amended

  agilon health, inc. entered into an Amended and Restated Employment Agreement with Jeffrey Schwaneke, Chief Financial Officer and Executive Vice President, effective January 1, 2026.

• Significant Equity Awards Granted

  The agreement includes a one-time grant of 600,000 restricted stock units (RSUs) and an aggregate grant-date fair value of $3,750,000 for fiscal year 2026 annual equity awards.

• Enhanced Severance Provisions

  The agreement outlines severance terms, including 12 months of base salary and target annual bonus, plus continued vesting of equity awards, if employment is terminated without cause under specified conditions.

auto_awesomeAnalysis

The amended employment agreement for CFO Jeffrey Schwaneke includes a one-time grant of 600,000 restricted stock units and an additional $3.75 million in annual equity awards for fiscal year 2026. This substantial compensation package, valued at over $4.2 million for FY2026 alone, represents a significant commitment of future equity, which could lead to notable dilution for existing shareholders. The agreement also provides for generous severance terms, including continued equity vesting, underscoring the company's efforts to retain key executive talent. Investors should monitor the impact of these awards on the company's share count and overall compensation expenses.